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Table C4: Estimates of the sample average treatment effect for the telehealth patients 
(figures are for the incidence rate ratio for the trial intervention group, except for 
mortality, where figures are for the odds ratio)  
  Generalized linear modeling Time series 
 
Comparison with 
RCT control 
group 
Comparison with 
non-participants 
Comparison with 
RCT control 
group 
Comparison with 
non-participants 
Emergency 
admissions per 
head 
0.90 
 (0.77, 1.05) 
1.12 
(0.95, 1.31) 
0.77 
 (0.66, 0.91) 
1.10 
 (0.92, 1.31) 
Elective 
admissions per 
head 
0.95 
 (0.80, 1.14) 
0.87 
(0.73, 1.05) 
0.72 
 (0.58, 0.90) 
0.75 
 (0.58, 0.98) 
Outpatient 
attendances per 
head 
1.02 
(0.93, 1.12) 
1.04 
(0.95, 1.14) 
1.00 
 (0.92, 1.10) 
1.02 
 (0.93, 1.12) 
Emergency room 
visits per head 
0.86 
(0.74, 0.99) 
0.96
(0.83, 1.11) 
0.66
 (0.56, 0.78) 
0.95
(0.80, 1.13) 
Primary care 
contacts per 
head 
1.06 
(1.01, 1.13) 
1.04 
(0.99, 1.09) 
1.09 
 (1.04, 1.16) 
1.06 
(1.01, 1.11) 
Mortality 
0.41 
(0.13, 1.23) 
1.50
(0.57, 3.94) 
n/a n/a 
Note: Time series models were not defined for mortality, as no deaths occurred before the 
date of enrolment into the trial. 
 
 
